MA40642A - Nouveaux dérivés peptidiques et leurs utilisations - Google Patents
Nouveaux dérivés peptidiques et leurs utilisationsInfo
- Publication number
- MA40642A MA40642A MA040642A MA40642A MA40642A MA 40642 A MA40642 A MA 40642A MA 040642 A MA040642 A MA 040642A MA 40642 A MA40642 A MA 40642A MA 40642 A MA40642 A MA 40642A
- Authority
- MA
- Morocco
- Prior art keywords
- peptide derivatives
- novel peptide
- compositions
- same
- novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La présente invention concerne de nouveaux dérivés peptidiques et des compositions comprenant ces derniers. L'invention concerne en outre des procédés de traitement comprenant l'administration de nouveaux dérivés peptidiques et/ou de compositions comprenant ces derniers.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14306504 | 2014-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA40642A true MA40642A (fr) | 2016-03-31 |
Family
ID=51663118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA040642A MA40642A (fr) | 2014-09-26 | 2015-09-25 | Nouveaux dérivés peptidiques et leurs utilisations |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10626144B2 (fr) |
| EP (1) | EP3197908A1 (fr) |
| JP (2) | JP7123559B2 (fr) |
| KR (1) | KR102522224B1 (fr) |
| CN (1) | CN106715460B (fr) |
| AU (1) | AU2015323713B2 (fr) |
| BR (1) | BR112017005993A2 (fr) |
| CA (1) | CA2961297C (fr) |
| IL (1) | IL251289B (fr) |
| MA (1) | MA40642A (fr) |
| MX (1) | MX383460B (fr) |
| RU (1) | RU2699572C2 (fr) |
| WO (1) | WO2016046409A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX383460B (es) * | 2014-09-26 | 2025-03-13 | Nosopharm | Derivados peptidicos novedosos y sus usos. |
| CN113185549A (zh) * | 2021-04-30 | 2021-07-30 | 河北农业大学 | 一种Wittig-Horner试剂的制备方法 |
| WO2024200838A1 (fr) | 2023-03-31 | 2024-10-03 | Nosopharm | Nouveaux analogues d'odilorhabdines utilisés en tant qu'antibiotiques contre des bactéries multirésistantes |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1451623A (fr) | 1964-09-29 | 1966-01-07 | Associated Semiconductor Mft | Procédé d'application d'une couche de bioxyde de germanium tétragonal sur un corps de germanium |
| WO2001021189A1 (fr) * | 1999-07-19 | 2001-03-29 | Epimmune Inc. | Induction de reponses immunitaires cellulaires au virus de l'hepatite c mettant en oeuvre des compositions de peptides et d'acide nucleique |
| WO2007133689A2 (fr) * | 2006-05-12 | 2007-11-22 | Cell Signaling Technology, Inc. | Réactifs pour la détection des chemins de signalisation de l'acétylation des protéines |
| EP2254592B1 (fr) * | 2008-02-28 | 2019-06-05 | Dako Denmark A/S | Multimères de mhc dans le diagnostic et le traitement de la borréliose |
| IN2014DN03010A (fr) * | 2011-09-28 | 2015-05-08 | Nosopharm | |
| WO2013171753A1 (fr) | 2012-05-16 | 2013-11-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Procédés de traitement et de diagnostic de maladies en utilisant des agents qui régulent les voies d'épissage alternatif |
| MX383460B (es) | 2014-09-26 | 2025-03-13 | Nosopharm | Derivados peptidicos novedosos y sus usos. |
-
2015
- 2015-09-25 MX MX2017003949A patent/MX383460B/es unknown
- 2015-09-25 AU AU2015323713A patent/AU2015323713B2/en not_active Ceased
- 2015-09-25 CA CA2961297A patent/CA2961297C/fr active Active
- 2015-09-25 JP JP2017516363A patent/JP7123559B2/ja active Active
- 2015-09-25 KR KR1020177010686A patent/KR102522224B1/ko active Active
- 2015-09-25 BR BR112017005993A patent/BR112017005993A2/pt not_active Application Discontinuation
- 2015-09-25 EP EP15775139.7A patent/EP3197908A1/fr active Pending
- 2015-09-25 WO PCT/EP2015/072185 patent/WO2016046409A1/fr not_active Ceased
- 2015-09-25 RU RU2017112510A patent/RU2699572C2/ru active
- 2015-09-25 US US15/507,934 patent/US10626144B2/en active Active
- 2015-09-25 CN CN201580051822.5A patent/CN106715460B/zh active Active
- 2015-09-25 MA MA040642A patent/MA40642A/fr unknown
-
2017
- 2017-03-20 IL IL251289A patent/IL251289B/en active IP Right Grant
-
2021
- 2021-03-01 JP JP2021032140A patent/JP2021100939A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20170298097A1 (en) | 2017-10-19 |
| CA2961297A1 (fr) | 2016-03-31 |
| WO2016046409A1 (fr) | 2016-03-31 |
| CA2961297C (fr) | 2024-06-04 |
| KR102522224B1 (ko) | 2023-04-14 |
| AU2015323713A1 (en) | 2017-04-20 |
| RU2017112510A (ru) | 2018-11-01 |
| IL251289B (en) | 2021-02-28 |
| CN106715460B (zh) | 2022-04-08 |
| BR112017005993A2 (pt) | 2017-12-19 |
| KR20170057400A (ko) | 2017-05-24 |
| JP2021100939A (ja) | 2021-07-08 |
| CN106715460A (zh) | 2017-05-24 |
| EP3197908A1 (fr) | 2017-08-02 |
| JP7123559B2 (ja) | 2022-08-23 |
| AU2015323713B2 (en) | 2020-04-23 |
| IL251289A0 (en) | 2017-05-29 |
| US10626144B2 (en) | 2020-04-21 |
| MX2017003949A (es) | 2018-01-12 |
| JP2017533890A (ja) | 2017-11-16 |
| RU2017112510A3 (fr) | 2019-02-25 |
| RU2699572C2 (ru) | 2019-09-06 |
| MX383460B (es) | 2025-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202107931B (en) | Anti-tau antibodies and methods of use | |
| CY1124013T1 (el) | Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη | |
| CY1120373T1 (el) | Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη | |
| MX2020005213A (es) | Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos. | |
| MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
| MX2019001471A (es) | Anticuerpos anti-siglec-7 para el tratamiento del cancer. | |
| MX2018009325A (es) | Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn). | |
| PH12017500877B1 (en) | ANTI-CD79b ANTIBODIES AND METHODS OF USE | |
| PH12016501441A1 (en) | Chimeric alkaline phosphate-like proteins | |
| GB2541571A (en) | Pharmaceutical compositions | |
| EA201691594A1 (ru) | Циклопропиламины в качестве ингибиторов lsd1 | |
| MY176855A (en) | Anti-jagged1 antibodies and methods of use | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| MX2017004808A (es) | Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple. | |
| EA201791454A1 (ru) | Лекарственные формы для трансдермального введения | |
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| PH12017501864A1 (en) | Compositions and methods for treating autism | |
| ZA201703467B (en) | Methods of treating ocular conditions | |
| PH12017502028A1 (en) | Vortioxetine pyroglutamate | |
| IN2014CH00840A (fr) | ||
| MX382092B (es) | Compuestos heterocíclicos para el tratamiento de enfermedades. | |
| HK1254231A1 (zh) | 米托-和厚朴酚化合物及其合成方法和用途 | |
| PH12016501838A1 (en) | Compounds and their methods of use | |
| PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
| MX2019005294A (es) | Inhibidores de las interacciones de mtor-deptor y metodos de uso de los mismos. |